CDEK
← All organizations

Synergy Pharmaceuticals

For profitContributed to NME

Also known as: Shanghai Synergy Pharmaceutical Sciences Co., Ltd. | Synergy Pharmaceuticals Inc. | Synergy Pharmaceuticals Pte. Ltd. | SYNERGY PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2010

First marketed drug

Jan 19, 2017

First NDA

Jan 19, 2017

Last known activity

Jun 1, 2024

Acquired by Bausch Health Companies on Mar 16, 2019

Timeline

2000s

  1. Jul 1, 2005

    Synergy Pharmaceuticals— Founded

2010s

  1. Jul 23, 2012

    Callisto Pharmaceuticals— Acquired

  2. Jan 19, 2017

    plecanatide— NDA Organization

  3. Jan 19, 2017

    plecanatide— NDA Secondary Org

  4. Mar 16, 2019

    Bausch Health Companies— Acquired By

Drugs by trial phase (8 distinct, 26 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (25)

Details

Founded
New York, NY, US Jul 1, 2005
First NDA
Jan 19, 2017
Last known activity
Jun 1, 2024